Actively Recruiting
Reducing Opioid Use for Chronic Pain Patients Following Surgery
Led by University Health Network, Toronto · Updated on 2026-04-30
210
Participants Needed
1
Research Sites
428 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Patients with chronic pain are often prescribed long-term opioid therapy, despite the serious risks and growing concerns related to opioid use. The Toronto General Hospital has created the world's first multidisciplinary perioperative Transitional Pain Service Program (TPSP) aimed at reducing the incidence and severity of chronic post-surgical pain. The TPSP incorporates a variety of mechanisms and interventions to help patients manage pain and to wean off opioids. The approach consists of: pain education, Acceptance and Commitment Therapy (ACT), and an e-mobile self- management tool to help patients manage chronic pain more effectively. With the TPSP team, the investigators hope to continually assist patients to achieve a balance between the benefits and potential harms of opioid use to promote long-term health and well-being.
CONDITIONS
Official Title
Reducing Opioid Use for Chronic Pain Patients Following Surgery
Who Can Participate
Eligibility Criteria
You may qualify if you...
- 18 years of age or older
- Taking 10 to 400 mg of preoperative oral morphine equivalents daily
- Undergoing any type of surgical procedure except palliative intent or organ transplantation
- Able to read and understand English for questionnaire surveys
- Taking opioids for at least one month before their operation
- Have a personal email address to set up the Manage My Pain app or online multimedia tool
You will not qualify if you...
- Receiving palliative care or undergoing palliative procedures
- Undergoing organ transplantation
- Prescribed Methadone or Buprenorphine
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Toronto General Hospital- University Health Network
Toronto, Ontario, Canada, M5G 2N2
Actively Recruiting
Research Team
K
Karim Ladha, MD
CONTACT
H
Hance Clarke, MD, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
HEALTH_SERVICES_RESEARCH
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here